View in EDS HTML Full Text PDF Full Text

Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.

Saved in:
Bibliographic Details
Title: Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.
Authors: Verrou E; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Koutoukoglou P; First Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Kontana E; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Gogolopoulos S; Second Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Sevastoudi A; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Daiou A; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Dalampira D; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Triantafyllou T; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Radounislis A; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Karampatzakis N; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Papadopoulou T; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece., Giannouli E; Immunology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece., Bouliopoulos GP; Hematology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece., Yiannaki E; Hematology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece., Tzimou M; Second Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Polychronidou G; First Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Papalexandri A; Molecular Diagnostics Laboratory, Hematology Department and BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece., Boutis A; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece., Katodritou E; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
Source: International journal of cancer [Int J Cancer] 2025 May 01; Vol. 156 (9), pp. 1686-1691. Date of Electronic Publication: 2024 Dec 17.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39686855
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Verrou+E%22">Verrou E</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Koutoukoglou+P%22">Koutoukoglou P</searchLink>; First Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Kontana+E%22">Kontana E</searchLink>; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Gogolopoulos+S%22">Gogolopoulos S</searchLink>; Second Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Sevastoudi+A%22">Sevastoudi A</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Daiou+A%22">Daiou A</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Dalampira+D%22">Dalampira D</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Triantafyllou+T%22">Triantafyllou T</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Radounislis+A%22">Radounislis A</searchLink>; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Karampatzakis+N%22">Karampatzakis N</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Papadopoulou+T%22">Papadopoulou T</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Giannouli+E%22">Giannouli E</searchLink>; Immunology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Bouliopoulos+GP%22">Bouliopoulos GP</searchLink>; Hematology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Yiannaki+E%22">Yiannaki E</searchLink>; Hematology Laboratory, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Tzimou+M%22">Tzimou M</searchLink>; Second Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Polychronidou+G%22">Polychronidou G</searchLink>; First Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Papalexandri+A%22">Papalexandri A</searchLink>; Molecular Diagnostics Laboratory, Hematology Department and BMT Unit, George Papanikolaou General Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Boutis+A%22">Boutis A</searchLink>; Third Department of Clinical Oncology, Theagenio Cancer Hospital, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Katodritou+E%22">Katodritou E</searchLink>; Hematology Department, Theagenio Cancer Hospital, Thessaloniki, Greece.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2025 May 01; Vol. 156 (9), pp. 1686-1691. <i>Date of Electronic Publication: </i>2024 Dec 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39686855
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ijc.35299
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1686
    Titles:
      – TitleFull: Incidence, characteristics and outcome of therapy-related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase inhibitors: A cancer center experience.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Verrou E
      – PersonEntity:
          Name:
            NameFull: Koutoukoglou P
      – PersonEntity:
          Name:
            NameFull: Kontana E
      – PersonEntity:
          Name:
            NameFull: Gogolopoulos S
      – PersonEntity:
          Name:
            NameFull: Sevastoudi A
      – PersonEntity:
          Name:
            NameFull: Daiou A
      – PersonEntity:
          Name:
            NameFull: Dalampira D
      – PersonEntity:
          Name:
            NameFull: Triantafyllou T
      – PersonEntity:
          Name:
            NameFull: Radounislis A
      – PersonEntity:
          Name:
            NameFull: Karampatzakis N
      – PersonEntity:
          Name:
            NameFull: Papadopoulou T
      – PersonEntity:
          Name:
            NameFull: Giannouli E
      – PersonEntity:
          Name:
            NameFull: Bouliopoulos GP
      – PersonEntity:
          Name:
            NameFull: Yiannaki E
      – PersonEntity:
          Name:
            NameFull: Tzimou M
      – PersonEntity:
          Name:
            NameFull: Polychronidou G
      – PersonEntity:
          Name:
            NameFull: Papalexandri A
      – PersonEntity:
          Name:
            NameFull: Boutis A
      – PersonEntity:
          Name:
            NameFull: Katodritou E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0215
          Numbering:
            – Type: volume
              Value: 156
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: International journal of cancer
              Type: main
ResultId 1